These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 7772017)

  • 1. Characterization of the ATPase activity of P-glycoprotein from multidrug-resistant Chinese hamster ovary cells.
    Sharom FJ; Yu X; Chu JW; Doige CA
    Biochem J; 1995 Jun; 308 ( Pt 2)(Pt 2):381-90. PubMed ID: 7772017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATPase activity of partially purified P-glycoprotein from multidrug-resistant Chinese hamster ovary cells.
    Doige CA; Yu X; Sharom FJ
    Biochim Biophys Acta; 1992 Aug; 1109(2):149-60. PubMed ID: 1355666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-glycoprotein is stably inhibited by vanadate-induced trapping of nucleotide at a single catalytic site.
    Urbatsch IL; Sankaran B; Weber J; Senior AE
    J Biol Chem; 1995 Aug; 270(33):19383-90. PubMed ID: 7642618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity.
    Borgnia MJ; Eytan GD; Assaraf YG
    J Biol Chem; 1996 Feb; 271(6):3163-71. PubMed ID: 8621716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and reconstitution of human P-glycoprotein.
    Ambudkar SV; Lelong IH; Zhang J; Cardarelli C
    Methods Enzymol; 1998; 292():492-504. PubMed ID: 9711577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of modulators on the ATPase activity and vanadate nucleotide trapping of human P-glycoprotein.
    Shepard RL; Winter MA; Hsaio SC; Pearce HL; Beck WT; Dantzig AH
    Biochem Pharmacol; 1998 Sep; 56(6):719-27. PubMed ID: 9751076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple purification of highly active biotinylated P-glycoprotein: enantiomer-specific modulation of drug-stimulated ATPase activity.
    Julien M; Kajiji S; Kaback RH; Gros P
    Biochemistry; 2000 Jan; 39(1):75-85. PubMed ID: 10625481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model.
    Garrigos M; Mir LM; Orlowski S
    Eur J Biochem; 1997 Mar; 244(2):664-73. PubMed ID: 9119038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATP hydrolysis by multidrug-resistance protein from Chinese hamster ovary cells.
    Senior AE; al-Shawi MK; Urbatsch IL
    J Bioenerg Biomembr; 1995 Feb; 27(1):31-6. PubMed ID: 7629049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the ATPase activity of purified Chinese hamster P-glycoprotein.
    Urbatsch IL; al-Shawi MK; Senior AE
    Biochemistry; 1994 Jun; 33(23):7069-76. PubMed ID: 7911680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transition state analysis of the coupling of drug transport to ATP hydrolysis by P-glycoprotein.
    Al-Shawi MK; Polar MK; Omote H; Figler RA
    J Biol Chem; 2003 Dec; 278(52):52629-40. PubMed ID: 14551217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents.
    Pascaud C; Garrigos M; Orlowski S
    Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):351-8. PubMed ID: 9657975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression system.
    Ramachandra M; Ambudkar SV; Gottesman MM; Pastan I; Hrycyna CA
    Mol Biol Cell; 1996 Oct; 7(10):1485-98. PubMed ID: 8898356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and functional reconstitution of the multidrug transporter.
    Sharom FJ
    J Bioenerg Biomembr; 1995 Feb; 27(1):15-22. PubMed ID: 7629046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cardiovascular drugs on ATPase activity of P-glycoprotein in plasma membranes and in purified reconstituted form.
    Rebbeor JF; Senior AE
    Biochim Biophys Acta; 1998 Feb; 1369(1):85-93. PubMed ID: 9528676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconstitution and functional studies of hamster P-glycoprotein in giant liposomes.
    Park S; Majd S
    PLoS One; 2018; 13(6):e0199279. PubMed ID: 29912971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis.
    Ambudkar SV; Lelong IH; Zhang J; Cardarelli CO; Gottesman MM; Pastan I
    Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8472-6. PubMed ID: 1356264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both P-glycoprotein nucleotide-binding sites are catalytically active.
    Urbatsch IL; Sankaran B; Bhagat S; Senior AE
    J Biol Chem; 1995 Nov; 270(45):26956-61. PubMed ID: 7592942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells.
    Regev R; Assaraf YG; Eytan GD
    Eur J Biochem; 1999 Jan; 259(1-2):18-24. PubMed ID: 9914470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis of a tryptophan-less P-glycoprotein: a tool for tryptophan insertion and fluorescence spectroscopy.
    Kwan T; Loughrey H; Brault M; Gruenheid S; Urbatsch IL; Senior AE; Gros P
    Mol Pharmacol; 2000 Jul; 58(1):37-47. PubMed ID: 10860925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.